Shardule Shah Named Blavatnik Fellow at Harvard Business School – INDIA New


The 2022-2023 Blavatnik Fellows (L-R): Shardule Shah, Hunter Goble, Matt Ross, Ilana Springer Borkenstein, Alexey Youssef. Photo courtesy Susan Young.

BOSTON—Harvard Business School (HBS) has named its 2022-23 Blavatnik Fellows and the program’s ninth cohort.

Launched in 2013, the Blavatnik Fellowship in Life Science Entrepreneurship is part of a gift to Harvard University from the Blavatnik Family Foundation. This program supports HBS alumni and Harvard-affiliated postdocs as they build their promising life science ventures by developing their leadership talents and providing mentorship and community during their entrepreneurial journey.

To date, Blavatnik Fellows have created 30 companies including a precision gene therapy, a respiratory dialysis device, a femtech device using genomics to enable women’s care, a biosensing wearable to prevent dehydration, and an oxygen sensor for personalized oncology care. They have collectively raised more than $485M in funding and an additional $244M from an IPO in June 2020. The Blavatnik Fellowship is led by Peter Barrett, PhD, faculty chair, and an advisory board of seasoned business and biotechnology leaders who serve as one-on-one mentors and provide strategic direction during the fellows’ program year.

“Since joining the Blavatnik Fellowship five years ago, the community has doubled in size and fellows’ companies funding has quadrupled. It is gratifying to be a part of the program’s tremendous growth and mentor next generation entrepreneurs who contribute to society by commercializing groundbreaking technology and biomedical innovation,” said Barrett. “This year’s fellows launched their ventures as MBA students and start their fellowship year with the largest seed financing raised as a new cohort. I am excited to work with them and carry on the program’s mission to inspire young life science entrepreneurs as they enter the Boston biotech ecosystem as Blavatnik Fellows.”

The 2022-2023 Blavatnik Fellows are:

Ilana Springer Borkenstein, RN (MBA 2022) is the co-founder and CEO of M7 Health, a technology company addressing the critical nursing shortage in the US. As a Blavatnik Fellow, Ilana will be focusing on M7 Health’s product development and go-to-market strategy. Prior to business school, Ilana was a registered nurse on the Bone Marrow Transplant and COVID-19 units at Memorial Sloan Kettering Cancer Center in New York City. She also brings operational experience from her roles at two early-stage health-tech startups, Elektra Health and Alula, and as a health care consultant at Deloitte. Ilana earned a BS in nursing from the University of Pennsylvania and an MBA from HBS.

Hunter Goble (MBA 2022) is the co-founder and CEO of Transcera, a biotech startup harnessing the biology of sphingolipids to enable oral delivery and amplified distribution of biologic medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin Wolfe, PhD. Hunter became passionate about life sciences at Eli Lilly & Company, where he worked on commercializing biologic therapies for autoimmune diseases. Leading market research and patient support program development gave Hunter a chance to interact with hundreds of patients and physicians who motivated him to learn more about sources of innovation in life sciences. He has also worked at Huron Consulting Group and Cured, a health tech startup. Hunter has a BA in political science from DePauw University and an MBA from HBS.

Matt Ross (MBA 2022) is the co-founder and CEO of Trove Health, which aims to become the world’s largest database of consented and identified patients for clinical research. During his Blavatnik Fellowship, he will focus on the development and commercialization of Trove Health’s core software platform, which is harnessing technology to solve the immense challenge around patient recruitment for clinical trials, where fewer than three percent of eligible patients enroll. Matt started Trove Health as a student with HBS Professor Satish Tadikonda, who developed their initial technology for patient identification and enrollment after decades of experience in the field. Matt has been passionate about helping patients through digital health platforms since he worked at Sanofi Genzyme and…



News Read More: Shardule Shah Named Blavatnik Fellow at Harvard Business School – INDIA New

Get real time updates directly on you device, subscribe now.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.